We are live on ! Find out more
WI

Wafra Inc Portfolio holdings

AUM $5.95M
1-Year Est. Return 6.19%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
-6.19%
3 Year Est. Return
-37.84%
5 Year Est. Return
-32.03%
10 Year Est. Return
+62.69%
AUM
$1.95B
AUM Growth
+$102M
Cap. Flow
-$12.5M
Cap. Flow %
-0.64%
Top 10 Hldgs %
65.76%
Holding
96
New
12
Increased
20
Reduced
17
Closed
12

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$23.9M
2
PG icon
Procter & Gamble
PG
+$16.7M
3
GILD icon
Gilead Sciences
GILD
+$12.5M
4
NKE icon
Nike
NKE
+$10.8M
5
NI icon
NiSource
NI
+$9.99M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$18.5M
2
KHC icon
Kraft Heinz
KHC
+$18.3M
3
TWX
Time Warner Inc
TWX
+$16.1M
4
D icon
Dominion Energy
D
+$9.5M
5
JPM icon
JPMorgan Chase
JPM
+$9.08M

Sector Composition

Rank Sector Weight
1 Technology 5.98%
2 Financials 5.78%
3 Consumer Discretionary 5.19%
4 Healthcare 5.14%
5 Communication Services 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UGP icon
76
Ultrapar
UGP
$6.95B
$525K 0.03%
46,196
JD icon
77
JD.com
JD
$44.6B
$451K 0.02%
14,504
CFMS
78
DELISTED
Conformis, Inc. Common Stock
CFMS
$327K 0.02%
2,504
CMA
79
DELISTED
Comerica
CMA
-55,686
Closed -$3.79M
D icon
80
Dominion Energy
D
$60.8B
-124,078
Closed -$9.5M
KHC icon
81
Kraft Heinz
KHC
$30.7B
-209,693
Closed -$18.3M
ORCL icon
82
Oracle
ORCL
$374B
-18,495
Closed -$711K
PCG icon
83
PG&E
PCG
$38.3B
-122,304
Closed -$7.43M
TRV icon
84
Travelers Companies
TRV
$78.1B
-52,062
Closed -$6.37M
WFC icon
85
Wells Fargo
WFC
$261B
-162,308
Closed -$8.95M
ZION icon
86
Zions Bancorporation
ZION
$10.2B
-87,902
Closed -$3.78M
AGN
87
DELISTED
Allergan plc
AGN
-87,922
Closed -$18.5M
TWX
88
DELISTED
Time Warner Inc
TWX
-166,322
Closed -$16.1M

Similar funds

Wafra Inc's Q1 2017 Portfolio in Review

As of Q1 2017, Wafra Inc held 96 positions worth $1.95B, up 5.5% from $1.85B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Wafra Inc's Q1 2017 filing shows 12 new, 20 increased, 17 reduced and 12 closed positions. Its largest new stake was Gilead Sciences: 178,246 shares worth $12.1M. The largest sale was Allergan plc, an estimated $18.5M.

By sector, the portfolio is most concentrated in Technology at 6% of assets, down from 6% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Wafra Inc's largest Q1 2017 buy was Gilead Sciences: 178,246 shares worth $12.1M.
  • Wafra Inc added most to Vanguard FTSE Developed Markets ETF in Q1 2017, an estimated $23.9M increase.
  • Wafra Inc's biggest Q1 2017 reduction was JPMorgan Chase, cutting an estimated $9.08M.
  • Wafra Inc fully exited Allergan plc in Q1 2017, selling an estimated $18.5M.
  • Wafra Inc's ten largest holdings make up 66% of its $1.95B portfolio in Q1 2017.
  • Wafra Inc opened 12 new positions and closed 12 in Q1 2017.
  • Wafra Inc's portfolio value rose 5.5% quarter-over-quarter to $1.95B.

Based on Wafra Inc's 13F filing for Q1 2017, filed 12 May 2017.